Literature DB >> 20142534

A novel POLG gene mutation in 4 children with Alpers-like hepatocerebral syndromes.

Bulent Kurt1, Jaak Jaeken, Johan Van Hove, Lieven Lagae, Ann Löfgren, David B Everman, Parul Jayakar, Ali Naini, Klaas J Wierenga, Gert Van Goethem, William C Copeland, Salvatore DiMauro.   

Abstract

OBJECTIVE: To describe a novel POLG missense mutation (c.3218C>T; p.P1073L) that, in association with 2 previously described mutations, caused an Alpers-like hepatocerebral syndrome in 4 children.
DESIGN: Genotype-phenotype correlation.
SETTING: Tertiary care universities. PATIENTS: Four children, 2 related and 2 unrelated, with the novel p.P1073L mutation (all patients) and either the p.A467T (2 patients), p.G848S (1 patient), or p.W748S (1 patient) mutation presented with psychomotor delay, encephalopathy, and liver failure.
INTERVENTIONS: Detailed clinical and laboratory examinations including brain magnetic resonance imaging, muscle biopsy, measurement of mitochondrial DNA, and sequencing of the POLG gene. MAIN OUTCOME MEASURES: Definition of clinical variability.
RESULTS: All 4 patients had psychomotor delay, seizures, and liver disease. Three patients had severe gastrointestinal dysmotility, which may be associated with the new p.P1073L mutation.
CONCLUSIONS: The heterozygous presence of the novel p.P1073L mutation in trans with another recessive POLG mutation causes a hepatocerebral disorder identical or very similar to Alpers syndrome. This adds to the already striking clinical heterogeneity of POLG mutations. In the Belgian patients, the familial occurrence without consanguinity is related to the high frequency of the recessive p.A467T and p.W748S mutations in northwestern Europe and reveals a pitfall for diagnosis and genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142534      PMCID: PMC3826985          DOI: 10.1001/archneurol.2009.332

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  19 in total

1.  Structure-function defects of human mitochondrial DNA polymerase in autosomal dominant progressive external ophthalmoplegia.

Authors:  Maria A Graziewicz; Matthew J Longley; Rachelle J Bienstock; Massimo Zeviani; William C Copeland
Journal:  Nat Struct Mol Biol       Date:  2004-07-18       Impact factor: 15.369

2.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions.

Authors:  G Van Goethem; B Dermaut; A Löfgren; J J Martin; C Van Broeckhoven
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

3.  Cloning and characterization of the human mitochondrial DNA polymerase, DNA polymerase gamma.

Authors:  P A Ropp; W C Copeland
Journal:  Genomics       Date:  1996-09-15       Impact factor: 5.736

4.  Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO).

Authors:  A Agostino; L Valletta; P F Chinnery; G Ferrari; F Carrara; R W Taylor; A M Schaefer; D M Turnbull; V Tiranti; M Zeviani
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

5.  Inducible expression of a dominant negative DNA polymerase-gamma depletes mitochondrial DNA and produces a rho0 phenotype.

Authors:  Mona Jazayeri; Alexander Andreyev; Yvonne Will; Manus Ward; Christen M Anderson; William Clevenger
Journal:  J Biol Chem       Date:  2003-03-14       Impact factor: 5.157

6.  Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma.

Authors:  Massimiliano Filosto; Michelangelo Mancuso; Yutaka Nishigaki; Jacklyn Pancrudo; Yadollah Harati; Clifton Gooch; Ami Mankodi; Lydia Bayne; Eduardo Bonilla; Sara Shanske; Michio Hirano; Salvatore DiMauro
Journal:  Arch Neurol       Date:  2003-09

7.  Mutational analysis of the human DNA polymerase alpha. The most conserved region in alpha-like DNA polymerases is involved in metal-specific catalysis.

Authors:  W C Copeland; T S Wang
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

Review 8.  Gastrointestinal manifestations of mitochondrial disease.

Authors:  Lynette A Gillis; Ronald J Sokol
Journal:  Gastroenterol Clin North Am       Date:  2003-09       Impact factor: 3.806

9.  Molecular and clinical genetics of mitochondrial diseases due to POLG mutations.

Authors:  Lee-Jun C Wong; Robert K Naviaux; Nicola Brunetti-Pierri; Qing Zhang; Eric S Schmitt; Cavatina Truong; Margherita Milone; Bruce H Cohen; Beverly Wical; Jaya Ganesh; Alice A Basinger; Barbara K Burton; Kathryn Swoboda; Donald L Gilbert; Adeline Vanderver; Russell P Saneto; Bruno Maranda; Georgianne Arnold; Jose E Abdenur; Paula J Waters; William C Copeland
Journal:  Hum Mutat       Date:  2008-09       Impact factor: 4.878

10.  POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy, ataxia, and deafness.

Authors:  M Mancuso; M Filosto; M Bellan; R Liguori; P Montagna; A Baruzzi; S DiMauro; V Carelli
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

View more
  7 in total

Review 1.  Mitochondrial deficiency in Cockayne syndrome.

Authors:  Morten Scheibye-Knudsen; Deborah L Croteau; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2013-02-19       Impact factor: 5.432

2.  Yeast cells expressing the human mitochondrial DNA polymerase reveal correlations between polymerase fidelity and human disease progression.

Authors:  Yufeng Qian; Aashiq H Kachroo; Christopher M Yellman; Edward M Marcotte; Kenneth A Johnson
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

3.  Mitochondrial diabetes is associated with insulin resistance in subcutaneous adipose tissue but not with increased liver fat content.

Authors:  Markus M Lindroos; Ronald Borra; Nina Mononen; Terho Lehtimäki; Kirsi A Virtanen; Virva Lepomäki; Letizia Guiducci; Patricia Iozzo; Kari Majamaa; Pirjo Nuutila
Journal:  J Inherit Metab Dis       Date:  2011-05-10       Impact factor: 4.982

4.  Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort.

Authors:  Cécile Rouzier; Annabelle Chaussenot; Valérie Serre; Konstantina Fragaki; Sylvie Bannwarth; Samira Ait-El-Mkadem; Shahram Attarian; Elsa Kaphan; Aline Cano; Emilien Delmont; Sabrina Sacconi; Bénédicte Mousson de Camaret; Marlène Rio; Anne-Sophie Lebre; Claude Jardel; Romain Deschamps; Christian Richelme; Jean Pouget; Brigitte Chabrol; Véronique Paquis-Flucklinger
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

5.  Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene.

Authors:  Ewa Pronicka; Anna Weglewska-Jurkiewicz; Maciej Pronicki; Jolanta Sykut-Cegielska; Pawel Kowalski; Magdalena Pajdowska; Irena Jankowska; Katarzyna Kotulska; Piotr Kalicinski; Joanna Jakobkiewicz-Banecka; Grzegorz Wegrzyn
Journal:  Med Sci Monit       Date:  2011-04

Review 6.  A Proposed Diagnostic Algorithm for Inborn Errors of Metabolism Presenting With Movements Disorders.

Authors:  Juan Darío Ortigoza-Escobar
Journal:  Front Neurol       Date:  2020-11-13       Impact factor: 4.003

7.  A multi-systemic mitochondrial disorder due to a dominant p.Y955H disease variant in DNA polymerase gamma.

Authors:  Triinu Siibak; Paula Clemente; Ana Bratic; Helene Bruhn; Timo E S Kauppila; Bertil Macao; Florian A Schober; Nicole Lesko; Rolf Wibom; Karin Naess; Inger Nennesmo; Anna Wedell; Bradley Peter; Christoph Freyer; Maria Falkenberg; Anna Wredenberg
Journal:  Hum Mol Genet       Date:  2017-07-01       Impact factor: 6.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.